Das Klinikum

Dr. Max Zimmermann

Dr. Max Zimmermann

Akademischer Mitarbeiter

My research interest focuses on understanding tumor aggressiveness and heterogeneity by multimodal imaging. Currently, I’m developing software for multimodal and hybrid imaging (MRI, hyperpolarized MRSI, PET, intravital microscopy) in order to quantify metabolic markers in the tumor microenvironment

Kontakt

Telefonnummer: 07071 29-87533

Faxnummer: 07071 29-4451

E-Mail-Adresse: max.zimmermann@med.uni-tuebingen.de

Klinik / Institut / Zentrum

  • Magnetic resonance imaging biomarkers for clinical routine assessment of microvascular architecture in glioma
  • MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas.
  • Intraoperative Magnetic Resonance Imaging of Cerebral Oxygen Metabolism During Resection of Brain Lesions.
  • Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia.
  • Vascular Hysteresis Loops and Vascular Architecture Mapping in Patients with Glioblastoma treated with Antiangiogenic Therapy.
  • Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma
  • Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans.
  • Comparative fMRI and MEG localization of cortical sensorimotor function: Bimodal mapping supports motor area reorganization in glioma patients.
  • Predicting Glioblastoma Response to Bevacizumab Through MRI Biomarkers of the Tumor Microenvironment.
  • Development of a Non-invasive Assessment of Hypoxia and Neovascularization with Magnetic Resonance Imaging in Benign and Malignant Breast Tumors: Initial Results.
  • Refined Functional Magnetic Resonance Imaging and Magnetoencephalography Mapping Reveals Reorganization in Language-Relevant Areas of Lesioned Brains.
  • Vascular architecture mapping for early detection of glioblastoma recurrence.
  • Non-Invasive Assessment of Hypoxia and Neovascularization with MRI for Identification of Aggressive Breast Cancer
  • Association between tissue hypoxia, perfusion restrictions, and microvascular architecture alterations with lesion-induced impairment of neurovascular coupling.